Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
CTMX
CytomX Therapeutics Inc
Biotechnology
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
CytomX Therapeutics Inc (CTMX) Earnings
Last reported
April 30, 2026
EPS estimate
-$0.12
EPS actual
—
Revenue est.
$4.8M
Revenue actual
—
Related:
CTMX overview
·
CTMX financials
·
CTMX news